J Am Coll Cardiol. 2021 Dec 07;78(23):2281-2290. doi: 10.1016/j.jacc.2021.09.1360.
Preeclampsia Predicts Risk of Hospitalization for Heart Failure With Preserved Ejection Fraction.
Journal of the American College of Cardiology
Dominique Williams, Molly J Stout, Joshua I Rosenbloom, Margaret A Olsen, Karen E Joynt Maddox, Elena Deych, Victor G Davila-Roman, Kathryn J Lindley
Affiliations
Affiliations
- Cardiovascular Imaging and Clinical Research Core Laboratory, Cardiovascular Division, Washington University in St Louis, St Louis, Missouri, USA.
- Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Washington University in St Louis, St Louis, Missouri, USA.
- Division of Infectious Diseases, Department of Medicine, Division of Public Health Sciences, Department of Surgery, Washington University in St Louis, St Louis, Missouri, USA.
- Cardiovascular Imaging and Clinical Research Core Laboratory, Cardiovascular Division, Washington University in St Louis, St Louis, Missouri, USA; Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Washington University in St Louis, St Louis, Missouri, USA. Electronic address: [email protected].
PMID: 34857089
PMCID: PMC8647839 DOI: 10.1016/j.jacc.2021.09.1360
Abstract
BACKGROUND: Preeclampsia is associated with increased risk of future heart failure (HF), but the relationship between preeclampsia and HF subtypes are not well-established.
OBJECTIVES: The objective of this analysis was to identify the risk of HF with preserved ejection fraction (HFpEF) following a delivery complicated by preeclampsia/eclampsia.
METHODS: A retrospective cohort study using the New York and Florida state Healthcare Cost and Utilization Project State Inpatient Databases identified delivery hospitalizations between 2006 and 2014 for women with and without preeclampsia/eclampsia. The authors identified women admitted for HF after discharge from index delivery hospitalization until September 30, 2015, using International Classification of Diseases-9th Revision-Clinical Modification diagnosis codes. Patients were followed from discharge to the first instance of primary outcome (HFpEF hospitalization), death, or end of study period. Secondary outcomes included hospitalization for any HF and HF with reduced ejection fraction, separately. The association between preeclampsia/eclampsia and HFpEF was analyzed using Cox proportional hazards models.
RESULTS: There were 2,532,515 women included in the study: 2,404,486 without and 128,029 with preeclampsia/eclampsia. HFpEF hospitalization was significantly more likely among women with preeclampsia/eclampsia, after adjusting for baseline hypertension and other covariates (aHR: 2.09; 95% CI: 1.80-2.44). Median time to onset of HFpEF was 32.2 months (interquartile range: 0.3-65.0 months), and median age at HFpEF onset was 34.0 years (interquartile range: 29.0-39.0 years). Both traditional (hypertension, diabetes mellitus) and sociodemographic (Black race, rurality, low income) risk factors were also associated with HFpEF and secondary outcomes.
CONCLUSIONS: Preeclampsia/eclampsia is an independent risk factor for future hospitalizations for HFpEF.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Keywords: HFpEF; heart failure; preeclampsia; pregnancy; women
Conflict of interest statement
Funding Support and Author Disclosures This study was supported in part by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR002345 from the National Center for Ad
References
- Pregnancy Hypertens. 2018 Jul;13:110-115 - PubMed
- BJOG. 2018 Dec;125(13):1642-1654 - PubMed
- Eur J Heart Fail. 2008 Feb;10(2):140-8 - PubMed
- JACC Cardiovasc Imaging. 2011 Jan;4(1):98-108 - PubMed
- MMWR Morb Mortal Wkly Rep. 2019 May 10;68(18):423-429 - PubMed
- Ann Epidemiol. 2019 May;33:30-36 - PubMed
- Obstet Gynecol. 2020 Jun;135(6):e237-e260 - PubMed
- Med Care. 1998 Jan;36(1):8-27 - PubMed
- Obstet Gynecol. 2020 Jan;135(1):27-35 - PubMed
- Pregnancy Hypertens. 2020 Jul;21:139-144 - PubMed
- Circ Heart Fail. 2018 Mar;11(3):e004457 - PubMed
- Circulation. 2019 Sep 24;140(13):1050-1060 - PubMed
- Circulation. 2005 Apr 26;111(16):2050-5 - PubMed
- Ultrasound Obstet Gynecol. 2017 Jan;49(1):143-149 - PubMed
- Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2): - PubMed
- Cardiovasc Diabetol. 2018 Sep 10;17(1):124 - PubMed
- Hypertension. 2020 Nov;76(5):1506-1513 - PubMed
- Int J Cardiovasc Imaging. 2020 Sep;36(9):1637-1645 - PubMed
- Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):1-7 - PubMed
- Am Heart J. 2008 Nov;156(5):918-30 - PubMed
- Circulation. 2018 Dec 11;138(24):2763-2773 - PubMed
- Circ Heart Fail. 2017 Jun;10(6): - PubMed
- Obstet Gynecol. 2019 Jan;133(1):e26-e50 - PubMed
- Am J Obstet Gynecol. 2019 Jun;220(6):582.e1-582.e11 - PubMed
- J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239 - PubMed
- Circulation. 2018 Mar 20;137(12):e67-e492 - PubMed
- Ann Intern Med. 2018 Aug 21;169(4):224-232 - PubMed
- J Card Fail. 2021 Feb;27(2):143-152 - PubMed
- J Am Coll Cardiol. 1995 Mar 15;25(4):879-84 - PubMed
- Obstet Gynecol. 2018 Nov;132(5):1158-1166 - PubMed
- Int J Cardiol. 2020 Apr 1;304:101-108 - PubMed
- J Am Coll Cardiol. 2013 Oct 29;62(18):1715-1723 - PubMed
- Med Care. 2017 Jul;55(7):698-705 - PubMed
- BMJ. 2007 Nov 10;335(7627):974 - PubMed
- J Womens Health (Larchmt). 2021 Jun;30(6):837-847 - PubMed
Publication Types
Grant support